无创多模态方法鉴别克罗恩病患者炎性与纤维性狭窄
综述回顾了无创技术评估克罗恩病肠道狭窄纤维化程度的方法,包括磁共振小肠造影、计算机断层扫描小肠造影、肠道超声、延迟钆增强、磁化传递磁共振成像、超声弹性成像及遗传、表观遗传和蛋白标志物分析,并讨论了扩散加权成像、应变弹性成像、剪切波成像和正电子发射断层扫描在指导治疗决策中的潜力。
要点
- 纤维性狭窄发生于30%的克罗恩病患者,尚无预防或逆转纤维性狭窄的治疗药物。
- 延迟钆增强、磁化传递磁共振成像和超声弹性成像似乎是评估克罗恩病患者纤维化的有前景工具。
- 鉴别狭窄中炎症与纤维化程度对选择最佳治疗很重要,但炎症与纤维化在受损肠段常不同程度共存。
核心结论
- 无创多模态方法有助于评估克罗恩病狭窄的纤维化程度,以指导治疗决策。
研究设计与样本
- 综述,评估克罗恩病纤维性狭窄的无创技术,包括影像学、遗传、表观遗传和蛋白标志物分析。
主要发现
- 纤维性狭窄发生于30%的克罗恩病患者,内镜下扩张和手术复发率高。
- 延迟钆增强、磁化传递磁共振成像和超声弹性成像似乎是评估纤维化的有前景工具。
- Rho相关蛋白激酶1和2抑制剂在慢性肠道炎症小鼠中逆转了纤维化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibrotic strictures occur in 30% of patients with Crohn's disease (CD). However, there are no therapeutic agents that prevent or reverse fibrotic strictures. Strictures are treated by endoscopic dilatation procedures and surgical procedures, but there are high rates of recurrence. Two antifibrotic agents (nintedanib and pirfenidone) recently were approved for the treatment of idiopathic pulmonary fibrosis and inhibitors of Rho-associated protein kinases 1 and 2 reversed fibrosis in mice with chronic intestinal inflammation. Cross-sectional imaging techniques, such as magnetic resonance (MR) enterography, computed tomography enterography, and bowel ultrasound, are used to assess small-bowel and CD-related complications, including strictures. It is important to be able to determine the degree of inflammation and fibrosis in strictures to select the best therapy; this can be a challenge because inflammation and fibrosis co-exist to varying degrees in a damaged bowel segment. Delayed gadolinium enhancement, magnetization transfer MR imaging, and ultrasound elastography seem to be promising tools for assessing fibrosis in patients with CD. We review noninvasive techniques for fibrosis assessment, including analyses of genetic, epigenetic, and protein markers. We discuss the potential of imaging techniques such as diffusion-weighted and magnetization transfer MR imaging, strain elastography, shear-wave imaging, and positron emission tomography to guide therapeutic decisions for patients with stricturing CD.
引用
- Allocca M, Fiorino G, Bonifacio C, et al. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2019. PMID: 30995529. doi:10.1016/j.cgh.2019.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。